APO Research
Talk to an analyst

APO RESEARCH · REPORT

Specific IgE Blood Based Allergy Testing

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Specific IgE Blood Based Allergy Testing Market Analysis and Forecast 2026-2032

3 May 2026220 pages

Choose your research edition.

Industry ResearchSpecific IgE Blood Based Allergy Testing Industry Research Report 2026137 pages · $2,950 USDIndustry Growth & TrendsGlobal Specific IgE Blood Based Allergy Testing Industry Growth and Trends Forecast to 2032124 pages · $3,450 USDMarket StructureGlobal Specific IgE Blood Based Allergy Testing Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032192 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Specific IgE Blood Based Allergy Testing Market Outlook and Growth Opportunities 2026192 pages · $4,250 USDMarket Analysis & ForecastGlobal Specific IgE Blood Based Allergy Testing Market Analysis and Forecast 2026-2032220 pages · $4,950 USD

Market perspective

The global Specific IgE Blood Based Allergy Testing market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for Specific IgE Blood Based Allergy Testing is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Specific IgE Blood Based Allergy Testing is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Specific IgE Blood Based Allergy Testing is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Specific IgE Blood Based Allergy Testing is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of Specific IgE Blood Based Allergy Testing include Phadia (Thermo Fisher Scientific), Medwiss Analytic, Euroimmun, Quest Diagnostics, Eurofins Biomnis, Siemens Healthineers, Labcorp, Novartis and Omega Diagnostics, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for Specific IgE Blood Based Allergy Testing, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Specific IgE Blood Based Allergy Testing, also provides the revenue of main regions and countries. Of the upcoming market potential for Specific IgE Blood Based Allergy Testing, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Specific IgE Blood Based Allergy Testing revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Specific IgE Blood Based Allergy Testing market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Specific IgE Blood Based Allergy Testing revenue, projected growth trends, production technology, application and end-user industry.

Specific IgE Blood Based Allergy Testing Segment by Company

Phadia (Thermo Fisher Scientific)

Medwiss Analytic

Euroimmun

Quest Diagnostics

Eurofins Biomnis

Siemens Healthineers

Labcorp

Novartis

Omega Diagnostics

Minaris Medical America

MacroArray Diagnostics

DST

HYCOR Biomedical

Everlywell

Abionic

Diagnostic Solutions Laboratory

MosaicDX

Lifelab Testing

HOB Biotech Group

Shenzhen Biocup Biotech

Hangzhou Zheda Dixun Biological Gene Engineering

ACON Biotech

Specific IgE Blood Based Allergy Testing Segment by Type

ELISA

FEIA

Others

Specific IgE Blood Based Allergy Testing Segment by Application

Hospitals

Clinics

Clinical Laboratories

Others

Specific IgE Blood Based Allergy Testing Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Specific IgE Blood Based Allergy Testing market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Specific IgE Blood Based Allergy Testing and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Specific IgE Blood Based Allergy Testing.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Specific IgE Blood Based Allergy Testing in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Specific IgE Blood Based Allergy Testing company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Specific IgE Blood Based Allergy Testing revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Specific IgE Blood Based Allergy Testing Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. ELISA Major Player Table 3. FEIA Major Player Table 4. Others Major Player Table 5. Global Specific IgE Blood Based Allergy Testing Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 6. Hospitals Major Player Table 7. Clinics Major Player Table 8. Clinical Laboratories Major Player Table 9. Others Major Player Table 10. Specific IgE Blood Based Allergy Testing Industry Trends Table 11. Specific IgE Blood Based Allergy Testing Industry Drivers Table 12. Specific IgE Blood Based Allergy Testing Industry Opportunities and Challenges Table 13. Specific IgE Blood Based Allergy Testing Industry Restraints Table 14. Global Specific IgE Blood Based Allergy Testing Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 15. Global Specific IgE Blood Based Allergy Testing Market Size by Region (2021-2026) & (US$ Million) Table 16. Global Specific IgE Blood Based Allergy Testing Market Share by Region (2021-2026) Table 17. Global Specific IgE Blood Based Allergy Testing Market Size by Region (2027-2032) & (US$ Million) Table 18. Global Specific IgE Blood Based Allergy Testing Market Share by Region (2027-2032) Table 19. Global Specific IgE Blood Based Allergy Testing Revenue by Players (US$ Million) & (2021-2026) Table 20. Global Specific IgE Blood Based Allergy Testing Revenue Market Share by Players (2021-2026) Table 21. Global Specific IgE Blood Based Allergy Testing Key Players Ranking, 2024 VS 2025 VS 2026 Table 22. Global Specific IgE Blood Based Allergy Testing Key Players Headquarters & Area Served Table 23. Global Specific IgE Blood Based Allergy Testing Players, Product Type & Application Table 24. Global Specific IgE Blood Based Allergy Testing Players Establishment Date Table 25. Global Players Market Concentration Ratio (CR5 and HHI) Table 26. Global Specific IgE Blood Based Allergy Testing by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 27. Global Specific IgE Blood Based Allergy Testing Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 28. Global Specific IgE Blood Based Allergy Testing Revenue by Type (2021-2026) & (US$ Million) Table 29. Global Specific IgE Blood Based Allergy Testing Revenue by Type (2027-2032) & (US$ Million) Table 30. Global Specific IgE Blood Based Allergy Testing Revenue Market Share by Type (2021-2026) Table 31. Global Specific IgE Blood Based Allergy Testing Revenue Market Share by Type (2027-2032) Table 32. Global Specific IgE Blood Based Allergy Testing Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 33. Global Specific IgE Blood Based Allergy Testing Revenue by Application (2021-2026) & (US$ Million) Table 34. Global Specific IgE Blood Based Allergy Testing Revenue by Application (2027-2032) & (US$ Million) Table 35. Global Specific IgE Blood Based Allergy Testing Revenue Market Share by Application (2021-2026) Table 36. Global Specific IgE Blood Based Allergy Testing Revenue Market Share by Application (2027-2032) Table 37. Phadia (Thermo Fisher Scientific) Company Information Table 38. Phadia (Thermo Fisher Scientific) Business Overview Table 39. Phadia (Thermo Fisher Scientific) Specific IgE Blood Based Allergy Testing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 40. Phadia (Thermo Fisher Scientific) Specific IgE Blood Based Allergy Testing Product Portfolio Table 41. Phadia (Thermo Fisher Scientific) Recent Development Table 42. Medwiss Analytic Company Information Table 43. Medwiss Analytic Business Overview Table 44. Medwiss Analytic Specific IgE Blood Based Allergy Testing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 45. Medwiss Analytic Specific IgE Blood Based Allergy Testing Product Portfolio Table 46. Medwiss Analytic Recent Development Table 47. Euroimmun Company Information Table 48. Euroimmun Business Overview Table 49. Euroimmun Specific IgE Blood Based Allergy Testing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 50. Euroimmun Specific IgE Blood Based Allergy Testing Product Portfolio Table 51. Euroimmun Recent Development Table 52. Quest Diagnostics Company Information Table 53. Quest Diagnostics Business Overview Table 54. Quest Diagnostics Specific IgE Blood Based Allergy Testing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 55. Quest Diagnostics Specific IgE Blood Based Allergy Testing Product Portfolio Table 56. Quest Diagnostics Recent Development Table 57. Eurofins Biomnis Company Information Table 58. Eurofins Biomnis Business Overview Table 59. Eurofins Biomnis Specific IgE Blood Based Allergy Testing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 60. Eurofins Biomnis Specific IgE Blood Based Allergy Testing Product Portfolio Table 61. Eurofins Biomnis Recent Development Table 62. Siemens Healthineers Company Information Table 63. Siemens Healthineers Business Overview Table 64. Siemens Healthineers Specific IgE Blood Based Allergy Testing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 65. Siemens Healthineers Specific IgE Blood Based Allergy Testing Product Portfolio Table 66. Siemens Healthineers Recent Development Table 67. Labcorp Company Information Table 68. Labcorp Business Overview Table 69. Labcorp Specific IgE Blood Based Allergy Testing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 70. Labcorp Specific IgE Blood Based Allergy Testing Product Portfolio Table 71. Labcorp Recent Development Table 72. Novartis Company Information Table 73. Novartis Business Overview Table 74. Novartis Specific IgE Blood Based Allergy Testing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 75. Novartis Specific IgE Blood Based Allergy Testing Product Portfolio Table 76. Novartis Recent Development Table 77. Omega Diagnostics Company Information Table 78. Omega Diagnostics Business Overview Table 79. Omega Diagnostics Specific IgE Blood Based Allergy Testing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 80. Omega Diagnostics Specific IgE Blood Based Allergy Testing Product Portfolio Table 81. Omega Diagnostics Recent Development Table 82. Minaris Medical America Company Information Table 83. Minaris Medical America Business Overview Table 84. Minaris Medical America Specific IgE Blood Based Allergy Testing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 85. Minaris Medical America Specific IgE Blood Based Allergy Testing Product Portfolio Table 86. Minaris Medical America Recent Development Table 87. MacroArray Diagnostics Company Information Table 88. MacroArray Diagnostics Business Overview Table 89. MacroArray Diagnostics Specific IgE Blood Based Allergy Testing Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 90. MacroArray Diagnostics Specific IgE Blood Based Allergy Testing Product Portfolio Table 91. MacroArray Diagnostics Recent Development Table 92. DST Company Information Table 93. DST Business Overview Table 94. DST Specific IgE Blood Based Allergy Testing Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 95. DST Specific IgE Blood Based Allergy Testing Product Portfolio Table 96. DST Recent Development Table 97. HYCOR Biomedical Company Information Table 98. HYCOR Biomedical Business Overview Table 99. HYCOR Biomedical Specific IgE Blood Based Allergy Testing Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 100. HYCOR Biomedical Specific IgE Blood Based Allergy Testing Product Portfolio Table 101. HYCOR Biomedical Recent Development Table 102. Everlywell Company Information Table 103. Everlywell Business Overview Table 104. Everlywell Specific IgE Blood Based Allergy Testing Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 105. Everlywell Specific IgE Blood Based Allergy Testing Product Portfolio Table 106. Everlywell Recent Development Table 107. Abionic Company Information Table 108. Abionic Business Overview Table 109. Abionic Specific IgE Blood Based Allergy Testing Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 110. Abionic Specific IgE Blood Based Allergy Testing Product Portfolio Table 111. Abionic Recent Development Table 112. Diagnostic Solutions Laboratory Company Information Table 113. Diagnostic Solutions Laboratory Business Overview Table 114. Diagnostic Solutions Laboratory Specific IgE Blood Based Allergy Testing Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 115. Diagnostic Solutions Laboratory Specific IgE Blood Based Allergy Testing Product Portfolio Table 116. Diagnostic Solutions Laboratory Recent Development Table 117. MosaicDX Company Information Table 118. MosaicDX Business Overview Table 119. MosaicDX Specific IgE Blood Based Allergy Testing Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 120. MosaicDX Specific IgE Blood Based Allergy Testing Product Portfolio Table 121. MosaicDX Recent Development Table 122. Lifelab Testing Company Information Table 123. Lifelab Testing Business Overview Table 124. Lifelab Testing Specific IgE Blood Based Allergy Testing Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 125. Lifelab Testing Specific IgE Blood Based Allergy Testing Product Portfolio Table 126. Lifelab Testing Recent Development Table 127. HOB Biotech Group Company Information Table 128. HOB Biotech Group Business Overview Table 129. HOB Biotech Group Specific IgE Blood Based Allergy Testing Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 130. HOB Biotech Group Specific IgE Blood Based Allergy Testing Product Portfolio Table 131. HOB Biotech Group Recent Development Table 132. Shenzhen Biocup Biotech Company Information Table 133. Shenzhen Biocup Biotech Business Overview Table 134. Shenzhen Biocup Biotech Specific IgE Blood Based Allergy Testing Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 135. Shenzhen Biocup Biotech Specific IgE Blood Based Allergy Testing Product Portfolio Table 136. Shenzhen Biocup Biotech Recent Development Table 137. Hangzhou Zheda Dixun Biological Gene Engineering Company Information Table 138. Hangzhou Zheda Dixun Biological Gene Engineering Business Overview Table 139. Hangzhou Zheda Dixun Biological Gene Engineering Specific IgE Blood Based Allergy Testing Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 140. Hangzhou Zheda Dixun Biological Gene Engineering Specific IgE Blood Based Allergy Testing Product Portfolio Table 141. Hangzhou Zheda Dixun Biological Gene Engineering Recent Development Table 142. ACON Biotech Company Information Table 143. ACON Biotech Business Overview Table 144. ACON Biotech Specific IgE Blood Based Allergy Testing Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 145. ACON Biotech Specific IgE Blood Based Allergy Testing Product Portfolio Table 146. ACON Biotech Recent Development Table 147. North America Specific IgE Blood Based Allergy Testing Revenue by Type (2021-2026) & (US$ Million) Table 148. North America Specific IgE Blood Based Allergy Testing Revenue by Type (2027-2032) & (US$ Million) Table 149. North America Specific IgE Blood Based Allergy Testing Revenue by Application (2021-2026) & (US$ Million) Table 150. North America Specific IgE Blood Based Allergy Testing Revenue by Application (2027-2032) & (US$ Million) Table 151. North America Specific IgE Blood Based Allergy Testing Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 152. North America Specific IgE Blood Based Allergy Testing Revenue by Country (2021-2026) & (US$ Million) Table 153. North America Specific IgE Blood Based Allergy Testing Revenue by Country (US$ Million) & (2027-2032) Table 154. Europe Specific IgE Blood Based Allergy Testing Revenue by Type (2021-2026) & (US$ Million) Table 155. Europe Specific IgE Blood Based Allergy Testing Revenue by Type (2027-2032) & (US$ Million) Table 156. Europe Specific IgE Blood Based Allergy Testing Revenue by Application (2021-2026) & (US$ Million) Table 157. Europe Specific IgE Blood Based Allergy Testing Revenue by Application (2027-2032) & (US$ Million) Table 158. Europe Specific IgE Blood Based Allergy Testing Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 159. Europe Specific IgE Blood Based Allergy Testing Revenue by Country (2021-2026) & (US$ Million) Table 160. Europe Specific IgE Blood Based Allergy Testing Revenue by Country (US$ Million) & (2027-2032) Table 161. China Specific IgE Blood Based Allergy Testing Revenue by Type (2021-2026) & (US$ Million) Table 162. China Specific IgE Blood Based Allergy Testing Revenue by Type (2027-2032) & (US$ Million) Table 163. China Specific IgE Blood Based Allergy Testing Revenue by Application (2021-2026) & (US$ Million) Table 164. China Specific IgE Blood Based Allergy Testing Revenue by Application (2027-2032) & (US$ Million) Table 165. Asia Specific IgE Blood Based Allergy Testing Revenue by Type (2021-2026) & (US$ Million) Table 166. Asia Specific IgE Blood Based Allergy Testing Revenue by Type (2027-2032) & (US$ Million) Table 167. Asia Specific IgE Blood Based Allergy Testing Revenue by Application (2021-2026) & (US$ Million) Table 168. Asia Specific IgE Blood Based Allergy Testing Revenue by Application (2027-2032) & (US$ Million) Table 169. Asia Specific IgE Blood Based Allergy Testing Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 170. Asia Specific IgE Blood Based Allergy Testing Revenue by Region (US$ Million) & (2021-2026) Table 171. Asia Specific IgE Blood Based Allergy Testing Revenue by Region (US$ Million) & (2027-2032) Table 172. SAMEA Specific IgE Blood Based Allergy Testing Revenue by Type (2021-2026) & (US$ Million) Table 173. SAMEA Specific IgE Blood Based Allergy Testing Revenue by Type (2027-2032) & (US$ Million) Table 174. SAMEA Specific IgE Blood Based Allergy Testing Revenue by Application (2021-2026) & (US$ Million) Table 175. SAMEA Specific IgE Blood Based Allergy Testing Revenue by Application (2027-2032) & (US$ Million) Table 176. SAMEA Specific IgE Blood Based Allergy Testing Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 177. SAMEA Specific IgE Blood Based Allergy Testing Revenue by Country (2021-2026) & (US$ Million) Table 178. SAMEA Specific IgE Blood Based Allergy Testing Revenue by Country (US$ Million) & (2027-2032) Table 179. Research Programs/Design for This Report Table 180. Authors List of This Report Table 181. Secondary Sources Table 182. Primary Sources List of Figures Figure 1. Specific IgE Blood Based Allergy Testing Image Figure 2. Global Specific IgE Blood Based Allergy Testing Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Specific IgE Blood Based Allergy Testing Market Size Share 2021 VS 2025 VS 2032 Figure 4. ELISA Image Figure 5. FEIA Image Figure 6. Others Image Figure 7. Global Specific IgE Blood Based Allergy Testing Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 8. Global Specific IgE Blood Based Allergy Testing Market Size Share 2021 VS 2025 VS 2032 Figure 9. Hospitals Image Figure 10. Clinics Image Figure 11. Clinical Laboratories Image Figure 12. Others Image Figure 13. Global Specific IgE Blood Based Allergy Testing Market Size (US$ Million) & (2021-2032) Figure 14. Global Specific IgE Blood Based Allergy Testing Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 15. Global Specific IgE Blood Based Allergy Testing Market Share by Region: 2021 VS 2025 VS 2032 Figure 16. Global Specific IgE Blood Based Allergy Testing Players Revenue Share Top 10 and Top 5 in 2025 Figure 17. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 18. Global Specific IgE Blood Based Allergy Testing Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 19. Global Specific IgE Blood Based Allergy Testing Revenue Market Share 2021 VS 2025 VS 2032 Figure 20. Global Specific IgE Blood Based Allergy Testing Revenue Market Share by Type (2021-2032) Figure 21. Global Specific IgE Blood Based Allergy Testing Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 22. Global Specific IgE Blood Based Allergy Testing Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 23. Global Specific IgE Blood Based Allergy Testing Revenue Market Share by Application (2021-2032) Figure 24. North America Specific IgE Blood Based Allergy Testing Revenue YoY Growth (2021-2032) & (US$ Million) Figure 25. North America Specific IgE Blood Based Allergy Testing Revenue Share by Type (2021-2032) Figure 26. North America Specific IgE Blood Based Allergy Testing Revenue Share by Application (2021-2032) Figure 27. North America Specific IgE Blood Based Allergy Testing Revenue Share by Country (2021-2032) Figure 28. United States Specific IgE Blood Based Allergy Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 29. Canada Specific IgE Blood Based Allergy Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 30. Mexico Specific IgE Blood Based Allergy Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 31. Europe Specific IgE Blood Based Allergy Testing Revenue YoY Growth (2021-2032) & (US$ Million) Figure 32. Europe Specific IgE Blood Based Allergy Testing Revenue Share by Type (2021-2032) Figure 33. Europe Specific IgE Blood Based Allergy Testing Revenue Share by Application (2021-2032) Figure 34. Europe Specific IgE Blood Based Allergy Testing Revenue Share by Country (2021-2032) Figure 35. Germany Specific IgE Blood Based Allergy Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 36. France Specific IgE Blood Based Allergy Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. U.K. Specific IgE Blood Based Allergy Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. Italy Specific IgE Blood Based Allergy Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Spain Specific IgE Blood Based Allergy Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Russia Specific IgE Blood Based Allergy Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. Netherlands Specific IgE Blood Based Allergy Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 42. Nordic Countries Specific IgE Blood Based Allergy Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 43. China Specific IgE Blood Based Allergy Testing Revenue YoY Growth (2021-2032) & (US$ Million) Figure 44. China Specific IgE Blood Based Allergy Testing Revenue Share by Type (2021-2032) Figure 45. China Specific IgE Blood Based Allergy Testing Revenue Share by Application (2021-2032) Figure 46. Asia Specific IgE Blood Based Allergy Testing Revenue YoY Growth (2021-2032) & (US$ Million) Figure 47. Asia Specific IgE Blood Based Allergy Testing Revenue Share by Type (2021-2032) Figure 48. Asia Specific IgE Blood Based Allergy Testing Revenue Share by Application (2021-2032) Figure 49. Asia Specific IgE Blood Based Allergy Testing Revenue Share by Region (2021-2032) Figure 50. Japan Specific IgE Blood Based Allergy Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 51. South Korea Specific IgE Blood Based Allergy Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. India Specific IgE Blood Based Allergy Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. Australia Specific IgE Blood Based Allergy Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. Taiwan Specific IgE Blood Based Allergy Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 55. Southeast Asia Specific IgE Blood Based Allergy Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 56. SAMEA Specific IgE Blood Based Allergy Testing Revenue YoY Growth (2021-2032) & (US$ Million) Figure 57. SAMEA Specific IgE Blood Based Allergy Testing Revenue Share by Type (2021-2032) Figure 58. SAMEA Specific IgE Blood Based Allergy Testing Revenue Share by Application (2021-2032) Figure 59. SAMEA Specific IgE Blood Based Allergy Testing Revenue Share by Country (2021-2032) Figure 60. Brazil Specific IgE Blood Based Allergy Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 61. Argentina Specific IgE Blood Based Allergy Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Chile Specific IgE Blood Based Allergy Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Colombia Specific IgE Blood Based Allergy Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Peru Specific IgE Blood Based Allergy Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. Saudi Arabia Specific IgE Blood Based Allergy Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. Israel Specific IgE Blood Based Allergy Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. UAE Specific IgE Blood Based Allergy Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Turkey Specific IgE Blood Based Allergy Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Iran Specific IgE Blood Based Allergy Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 70. Egypt Specific IgE Blood Based Allergy Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • ELISA
  • FEIA
  • Others
Applications
  • Hospitals
  • Clinics
  • Clinical Laboratories
  • Others
Companies covered
  • Phadia (Thermo Fisher Scientific)
  • Medwiss Analytic
  • Euroimmun
  • Quest Diagnostics
  • Eurofins Biomnis
  • Siemens Healthineers
  • Labcorp
  • Novartis
  • Omega Diagnostics
  • Minaris Medical America
  • MacroArray Diagnostics
  • DST
  • HYCOR Biomedical
  • Everlywell
  • Abionic
  • Diagnostic Solutions Laboratory
  • MosaicDX
  • Lifelab Testing
  • HOB Biotech Group
  • Shenzhen Biocup Biotech
  • Hangzhou Zheda Dixun Biological Gene Engineering
  • ACON Biotech

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Specific IgE Blood Based Allergy Testing Market by Type
  3. 1.2.1 Global Specific IgE Blood Based Allergy Testing Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 ELISA
  5. 1.2.3 FEIA
  6. 1.2.4 Others
  7. 1.3 Specific IgE Blood Based Allergy Testing Market by Application
  8. 1.3.1 Global Specific IgE Blood Based Allergy Testing Market Size by Application, 2021 VS 2025 VS 2032
  9. 1.3.2 Hospitals
  10. 1.3.3 Clinics
  11. 1.3.4 Clinical Laboratories
  12. 1.3.5 Others
  13. 1.4 Assumptions and Limitations
  14. 1.5 Study Goals and Objectives
2 Specific IgE Blood Based Allergy Testing Market Dynamics
  1. 2.1 Specific IgE Blood Based Allergy Testing Industry Trends
  2. 2.2 Specific IgE Blood Based Allergy Testing Industry Drivers
  3. 2.3 Specific IgE Blood Based Allergy Testing Industry Opportunities and Challenges
  4. 2.4 Specific IgE Blood Based Allergy Testing Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Specific IgE Blood Based Allergy Testing Market Perspective (2021-2032)
  2. 3.2 Global Specific IgE Blood Based Allergy Testing Growth Trends by Region
  3. 3.2.1 Global Specific IgE Blood Based Allergy Testing Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Specific IgE Blood Based Allergy Testing Market Size by Region (2021-2026)
  5. 3.2.3 Global Specific IgE Blood Based Allergy Testing Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Specific IgE Blood Based Allergy Testing Revenue by Players
  2. 4.1.1 Global Specific IgE Blood Based Allergy Testing Revenue by Players (2021-2026)
  3. 4.1.2 Global Specific IgE Blood Based Allergy Testing Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Specific IgE Blood Based Allergy Testing Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Specific IgE Blood Based Allergy Testing Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Specific IgE Blood Based Allergy Testing Key Players Headquarters & Area Served
  7. 4.4 Global Specific IgE Blood Based Allergy Testing Players, Product Type & Application
  8. 4.5 Global Specific IgE Blood Based Allergy Testing Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Specific IgE Blood Based Allergy Testing Market CR5 and HHI
  11. 4.6.3 2025 Specific IgE Blood Based Allergy Testing Tier 1, Tier 2, and Tier 3
5 Specific IgE Blood Based Allergy Testing Market Size by Type
  1. 5.1 Global Specific IgE Blood Based Allergy Testing Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Specific IgE Blood Based Allergy Testing Revenue by Type (2021-2032)
  3. 5.3 Global Specific IgE Blood Based Allergy Testing Revenue Market Share by Type (2021-2032)
6 Specific IgE Blood Based Allergy Testing Market Size by Application
  1. 6.1 Global Specific IgE Blood Based Allergy Testing Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Specific IgE Blood Based Allergy Testing Revenue by Application (2021-2032)
  3. 6.3 Global Specific IgE Blood Based Allergy Testing Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 Phadia (Thermo Fisher Scientific)
  2. 7.1.1 Phadia (Thermo Fisher Scientific) Company Information
  3. 7.1.2 Phadia (Thermo Fisher Scientific) Business Overview
  4. 7.1.3 Phadia (Thermo Fisher Scientific) Specific IgE Blood Based Allergy Testing Revenue and Gross Margin (2021-2026)
  5. 7.1.4 Phadia (Thermo Fisher Scientific) Specific IgE Blood Based Allergy Testing Product Portfolio
  6. 7.1.5 Phadia (Thermo Fisher Scientific) Recent Developments
  7. 7.2 Medwiss Analytic
  8. 7.2.1 Medwiss Analytic Company Information
  9. 7.2.2 Medwiss Analytic Business Overview
  10. 7.2.3 Medwiss Analytic Specific IgE Blood Based Allergy Testing Revenue and Gross Margin (2021-2026)
  11. 7.2.4 Medwiss Analytic Specific IgE Blood Based Allergy Testing Product Portfolio
  12. 7.2.5 Medwiss Analytic Recent Developments
  13. 7.3 Euroimmun
  14. 7.3.1 Euroimmun Company Information
  15. 7.3.2 Euroimmun Business Overview
  16. 7.3.3 Euroimmun Specific IgE Blood Based Allergy Testing Revenue and Gross Margin (2021-2026)
  17. 7.3.4 Euroimmun Specific IgE Blood Based Allergy Testing Product Portfolio
  18. 7.3.5 Euroimmun Recent Developments
  19. 7.4 Quest Diagnostics
  20. 7.4.1 Quest Diagnostics Company Information
  21. 7.4.2 Quest Diagnostics Business Overview
  22. 7.4.3 Quest Diagnostics Specific IgE Blood Based Allergy Testing Revenue and Gross Margin (2021-2026)
  23. 7.4.4 Quest Diagnostics Specific IgE Blood Based Allergy Testing Product Portfolio
  24. 7.4.5 Quest Diagnostics Recent Developments
  25. 7.5 Eurofins Biomnis
  26. 7.5.1 Eurofins Biomnis Company Information
  27. 7.5.2 Eurofins Biomnis Business Overview
  28. 7.5.3 Eurofins Biomnis Specific IgE Blood Based Allergy Testing Revenue and Gross Margin (2021-2026)
  29. 7.5.4 Eurofins Biomnis Specific IgE Blood Based Allergy Testing Product Portfolio
  30. 7.5.5 Eurofins Biomnis Recent Developments
  31. 7.6 Siemens Healthineers
  32. 7.6.1 Siemens Healthineers Company Information
  33. 7.6.2 Siemens Healthineers Business Overview
  34. 7.6.3 Siemens Healthineers Specific IgE Blood Based Allergy Testing Revenue and Gross Margin (2021-2026)
  35. 7.6.4 Siemens Healthineers Specific IgE Blood Based Allergy Testing Product Portfolio
  36. 7.6.5 Siemens Healthineers Recent Developments
  37. 7.7 Labcorp
  38. 7.7.1 Labcorp Company Information
  39. 7.7.2 Labcorp Business Overview
  40. 7.7.3 Labcorp Specific IgE Blood Based Allergy Testing Revenue and Gross Margin (2021-2026)
  41. 7.7.4 Labcorp Specific IgE Blood Based Allergy Testing Product Portfolio
  42. 7.7.5 Labcorp Recent Developments
  43. 7.8 Novartis
  44. 7.8.1 Novartis Company Information
  45. 7.8.2 Novartis Business Overview
  46. 7.8.3 Novartis Specific IgE Blood Based Allergy Testing Revenue and Gross Margin (2021-2026)
  47. 7.8.4 Novartis Specific IgE Blood Based Allergy Testing Product Portfolio
  48. 7.8.5 Novartis Recent Developments
  49. 7.9 Omega Diagnostics
  50. 7.9.1 Omega Diagnostics Company Information
  51. 7.9.2 Omega Diagnostics Business Overview
  52. 7.9.3 Omega Diagnostics Specific IgE Blood Based Allergy Testing Revenue and Gross Margin (2021-2026)
  53. 7.9.4 Omega Diagnostics Specific IgE Blood Based Allergy Testing Product Portfolio
  54. 7.9.5 Omega Diagnostics Recent Developments
  55. 7.10 Minaris Medical America
  56. 7.10.1 Minaris Medical America Company Information
  57. 7.10.2 Minaris Medical America Business Overview
  58. 7.10.3 Minaris Medical America Specific IgE Blood Based Allergy Testing Revenue and Gross Margin (2021-2026)
  59. 7.10.4 Minaris Medical America Specific IgE Blood Based Allergy Testing Product Portfolio
  60. 7.10.5 Minaris Medical America Recent Developments
  61. 7.11 MacroArray Diagnostics
  62. 7.11.1 MacroArray Diagnostics Company Information
  63. 7.11.2 MacroArray Diagnostics Business Overview
  64. 7.11.3 MacroArray Diagnostics Specific IgE Blood Based Allergy Testing Revenue and Gross Margin (2021-2026)
  65. 7.11.4 MacroArray Diagnostics Specific IgE Blood Based Allergy Testing Product Portfolio
  66. 7.11.5 MacroArray Diagnostics Recent Developments
  67. 7.12 DST
  68. 7.12.1 DST Company Information
  69. 7.12.2 DST Business Overview
  70. 7.12.3 DST Specific IgE Blood Based Allergy Testing Revenue and Gross Margin (2021-2026)
  71. 7.12.4 DST Specific IgE Blood Based Allergy Testing Product Portfolio
  72. 7.12.5 DST Recent Developments
  73. 7.13 HYCOR Biomedical
  74. 7.13.1 HYCOR Biomedical Company Information
  75. 7.13.2 HYCOR Biomedical Business Overview
  76. 7.13.3 HYCOR Biomedical Specific IgE Blood Based Allergy Testing Revenue and Gross Margin (2021-2026)
  77. 7.13.4 HYCOR Biomedical Specific IgE Blood Based Allergy Testing Product Portfolio
  78. 7.13.5 HYCOR Biomedical Recent Developments
  79. 7.14 Everlywell
  80. 7.14.1 Everlywell Company Information
  81. 7.14.2 Everlywell Business Overview
  82. 7.14.3 Everlywell Specific IgE Blood Based Allergy Testing Revenue and Gross Margin (2021-2026)
  83. 7.14.4 Everlywell Specific IgE Blood Based Allergy Testing Product Portfolio
  84. 7.14.5 Everlywell Recent Developments
  85. 7.15 Abionic
  86. 7.15.1 Abionic Company Information
  87. 7.15.2 Abionic Business Overview
  88. 7.15.3 Abionic Specific IgE Blood Based Allergy Testing Revenue and Gross Margin (2021-2026)
  89. 7.15.4 Abionic Specific IgE Blood Based Allergy Testing Product Portfolio
  90. 7.15.5 Abionic Recent Developments
  91. 7.16 Diagnostic Solutions Laboratory
  92. 7.16.1 Diagnostic Solutions Laboratory Company Information
  93. 7.16.2 Diagnostic Solutions Laboratory Business Overview
  94. 7.16.3 Diagnostic Solutions Laboratory Specific IgE Blood Based Allergy Testing Revenue and Gross Margin (2021-2026)
  95. 7.16.4 Diagnostic Solutions Laboratory Specific IgE Blood Based Allergy Testing Product Portfolio
  96. 7.16.5 Diagnostic Solutions Laboratory Recent Developments
  97. 7.17 MosaicDX
  98. 7.17.1 MosaicDX Company Information
  99. 7.17.2 MosaicDX Business Overview
  100. 7.17.3 MosaicDX Specific IgE Blood Based Allergy Testing Revenue and Gross Margin (2021-2026)
  101. 7.17.4 MosaicDX Specific IgE Blood Based Allergy Testing Product Portfolio
  102. 7.17.5 MosaicDX Recent Developments
  103. 7.18 Lifelab Testing
  104. 7.18.1 Lifelab Testing Company Information
  105. 7.18.2 Lifelab Testing Business Overview
  106. 7.18.3 Lifelab Testing Specific IgE Blood Based Allergy Testing Revenue and Gross Margin (2021-2026)
  107. 7.18.4 Lifelab Testing Specific IgE Blood Based Allergy Testing Product Portfolio
  108. 7.18.5 Lifelab Testing Recent Developments
  109. 7.19 HOB Biotech Group
  110. 7.19.1 HOB Biotech Group Company Information
  111. 7.19.2 HOB Biotech Group Business Overview
  112. 7.19.3 HOB Biotech Group Specific IgE Blood Based Allergy Testing Revenue and Gross Margin (2021-2026)
  113. 7.19.4 HOB Biotech Group Specific IgE Blood Based Allergy Testing Product Portfolio
  114. 7.19.5 HOB Biotech Group Recent Developments
  115. 7.20 Shenzhen Biocup Biotech
  116. 7.20.1 Shenzhen Biocup Biotech Company Information
  117. 7.20.2 Shenzhen Biocup Biotech Business Overview
  118. 7.20.3 Shenzhen Biocup Biotech Specific IgE Blood Based Allergy Testing Revenue and Gross Margin (2021-2026)
  119. 7.20.4 Shenzhen Biocup Biotech Specific IgE Blood Based Allergy Testing Product Portfolio
  120. 7.20.5 Shenzhen Biocup Biotech Recent Developments
  121. 7.21 Hangzhou Zheda Dixun Biological Gene Engineering
  122. 7.21.1 Hangzhou Zheda Dixun Biological Gene Engineering Company Information
  123. 7.21.2 Hangzhou Zheda Dixun Biological Gene Engineering Business Overview
  124. 7.21.3 Hangzhou Zheda Dixun Biological Gene Engineering Specific IgE Blood Based Allergy Testing Revenue and Gross Margin (2021-2026)
  125. 7.21.4 Hangzhou Zheda Dixun Biological Gene Engineering Specific IgE Blood Based Allergy Testing Product Portfolio
  126. 7.21.5 Hangzhou Zheda Dixun Biological Gene Engineering Recent Developments
  127. 7.22 ACON Biotech
  128. 7.22.1 ACON Biotech Company Information
  129. 7.22.2 ACON Biotech Business Overview
  130. 7.22.3 ACON Biotech Specific IgE Blood Based Allergy Testing Revenue and Gross Margin (2021-2026)
  131. 7.22.4 ACON Biotech Specific IgE Blood Based Allergy Testing Product Portfolio
  132. 7.22.5 ACON Biotech Recent Developments
8 North America
  1. 8.1 North America Specific IgE Blood Based Allergy Testing Revenue (2021-2032)
  2. 8.2 North America Specific IgE Blood Based Allergy Testing Revenue by Type (2021-2032)
  3. 8.2.1 North America Specific IgE Blood Based Allergy Testing Revenue by Type (2021-2026)
  4. 8.2.2 North America Specific IgE Blood Based Allergy Testing Revenue by Type (2027-2032)
  5. 8.3 North America Specific IgE Blood Based Allergy Testing Revenue Share by Type (2021-2032)
  6. 8.4 North America Specific IgE Blood Based Allergy Testing Revenue by Application (2021-2032)
  7. 8.4.1 North America Specific IgE Blood Based Allergy Testing Revenue by Application (2021-2026)
  8. 8.4.2 North America Specific IgE Blood Based Allergy Testing Revenue by Application (2027-2032)
  9. 8.5 North America Specific IgE Blood Based Allergy Testing Revenue Share by Application (2021-2032)
  10. 8.6 North America Specific IgE Blood Based Allergy Testing Revenue by Country
  11. 8.6.1 North America Specific IgE Blood Based Allergy Testing Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Specific IgE Blood Based Allergy Testing Revenue by Country (2021-2026)
  13. 8.6.3 North America Specific IgE Blood Based Allergy Testing Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
  16. 8.6.6 Mexico
9 Europe
  1. 9.1 Europe Specific IgE Blood Based Allergy Testing Revenue (2021-2032)
  2. 9.2 Europe Specific IgE Blood Based Allergy Testing Revenue by Type (2021-2032)
  3. 9.2.1 Europe Specific IgE Blood Based Allergy Testing Revenue by Type (2021-2026)
  4. 9.2.2 Europe Specific IgE Blood Based Allergy Testing Revenue by Type (2027-2032)
  5. 9.3 Europe Specific IgE Blood Based Allergy Testing Revenue Share by Type (2021-2032)
  6. 9.4 Europe Specific IgE Blood Based Allergy Testing Revenue by Application (2021-2032)
  7. 9.4.1 Europe Specific IgE Blood Based Allergy Testing Revenue by Application (2021-2026)
  8. 9.4.2 Europe Specific IgE Blood Based Allergy Testing Revenue by Application (2027-2032)
  9. 9.5 Europe Specific IgE Blood Based Allergy Testing Revenue Share by Application (2021-2032)
  10. 9.6 Europe Specific IgE Blood Based Allergy Testing Revenue by Country
  11. 9.6.1 Europe Specific IgE Blood Based Allergy Testing Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Specific IgE Blood Based Allergy Testing Revenue by Country (2021-2026)
  13. 9.6.3 Europe Specific IgE Blood Based Allergy Testing Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Russia
  19. 9.6.9 Spain
  20. 9.6.10 Netherlands
  21. 9.6.11 Switzerland
  22. 9.6.12 Sweden
  23. 9.6.13 Poland
10 China
  1. 10.1 China Specific IgE Blood Based Allergy Testing Revenue (2021-2032)
  2. 10.2 China Specific IgE Blood Based Allergy Testing Revenue by Type (2021-2032)
  3. 10.2.1 China Specific IgE Blood Based Allergy Testing Revenue by Type (2021-2026)
  4. 10.2.2 China Specific IgE Blood Based Allergy Testing Revenue by Type (2027-2032)
  5. 10.3 China Specific IgE Blood Based Allergy Testing Revenue Share by Type (2021-2032)
  6. 10.4 China Specific IgE Blood Based Allergy Testing Revenue by Application (2021-2032)
  7. 10.4.1 China Specific IgE Blood Based Allergy Testing Revenue by Application (2021-2026)
  8. 10.4.2 China Specific IgE Blood Based Allergy Testing Revenue by Application (2027-2032)
  9. 10.5 China Specific IgE Blood Based Allergy Testing Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Specific IgE Blood Based Allergy Testing Revenue (2021-2032)
  2. 11.2 Asia Specific IgE Blood Based Allergy Testing Revenue by Type (2021-2032)
  3. 11.2.1 Asia Specific IgE Blood Based Allergy Testing Revenue by Type (2021-2026)
  4. 11.2.2 Asia Specific IgE Blood Based Allergy Testing Revenue by Type (2027-2032)
  5. 11.3 Asia Specific IgE Blood Based Allergy Testing Revenue Share by Type (2021-2032)
  6. 11.4 Asia Specific IgE Blood Based Allergy Testing Revenue by Application (2021-2032)
  7. 11.4.1 Asia Specific IgE Blood Based Allergy Testing Revenue by Application (2021-2026)
  8. 11.4.2 Asia Specific IgE Blood Based Allergy Testing Revenue by Application (2027-2032)
  9. 11.5 Asia Specific IgE Blood Based Allergy Testing Revenue Share by Application (2021-2032)
  10. 11.6 Asia Specific IgE Blood Based Allergy Testing Revenue by Country
  11. 11.6.1 Asia Specific IgE Blood Based Allergy Testing Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Specific IgE Blood Based Allergy Testing Revenue by Country (2021-2026)
  13. 11.6.3 Asia Specific IgE Blood Based Allergy Testing Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Specific IgE Blood Based Allergy Testing Revenue (2021-2032)
  2. 12.2 SAMEA Specific IgE Blood Based Allergy Testing Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Specific IgE Blood Based Allergy Testing Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Specific IgE Blood Based Allergy Testing Revenue by Type (2027-2032)
  5. 12.3 SAMEA Specific IgE Blood Based Allergy Testing Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Specific IgE Blood Based Allergy Testing Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Specific IgE Blood Based Allergy Testing Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Specific IgE Blood Based Allergy Testing Revenue by Application (2027-2032)
  9. 12.5 SAMEA Specific IgE Blood Based Allergy Testing Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Specific IgE Blood Based Allergy Testing Revenue by Country
  11. 12.6.1 SAMEA Specific IgE Blood Based Allergy Testing Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Specific IgE Blood Based Allergy Testing Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Specific IgE Blood Based Allergy Testing Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst